IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...
The Tecnis Symfony IOL is the first intraocular lens able to allow cataract patients to have extended depth-of-focus, according to FDA. Chris Newmarker FDA recently announced approval of an ...
SIOUX CITY -- Two years ago, Mark Brewer received the Tecnis Symfony intraocular lens, the first intraocular lens to provides cataract patients with an extended depth-of-focus, at Jones Eye Clinic. At ...
Santa Ana-based Abbott Medical Optics, a unit of Abbott Laboratories in Chicago, scored a regulatory approval this month. Abbott Medical said the Food and Drug Administration approved its Tecnis ...
Please provide your email address to receive an email when new articles are posted on . An IOL with a violet light filter yielded less halo and starburst at 1 month vs. an IOL with an ultraviolet ...
Please provide your email address to receive an email when new articles are posted on . Part one of this series focused on balancing the three interrelated concepts of presbyopia-correcting or visual ...
The TECNIS® portfolio is the broadest mix of IOLs available worldwide, providing solutions for a variety of visual conditions to allow patients to See More In 2021, Johnson & Johnson Vision will ...
The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results